Home » Stocks » CLB

Core Laboratories N.V. (CLB)

Stock Price: $24.09 USD -0.39 (-1.59%)
Updated November 27, 1:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 1.07B
Revenue (ttm) 530.30M
Net Income (ttm) -100.84M
Shares Out 44.49M
EPS (ttm) -2.27
PE Ratio n/a
Forward PE 31.35
Dividend $0.04
Dividend Yield 0.17%

Stock Quote

Trading Day November 27
Last Price $24.09
Previous Close $24.48
Change ($) -0.39
Change (%) -1.59%
Day's Open 24.13
Day's Range 23.88 - 24.47
Day's Volume 199,274
52-Week Range 6.68 - 48.40

More Stats

Market Cap 1.07B
Enterprise Value 1.39B
Earnings Date (est) Feb 3, 2021
Ex-Dividend Date Oct 23, 2020
Shares Outstanding 44.49M
Float 43.96M
EPS (basic) -2.27
EPS (diluted) -2.27
FCF / Share 1.76
Dividend $0.04
Dividend Yield 0.17%
Earnings Yield n/a
FCF Yield 7.29%
Payout Ratio n/a
Shares Short 4.69M
Short Ratio 9.67
Short % of Float 10.68%
Beta 3.16
PE Ratio n/a
Forward PE 31.35
P/FCF Ratio 13.71
PS Ratio 2.02
PB Ratio 16.11
Revenue 530.30M
Operating Income -79.15M
Net Income -100.84M
Free Cash Flow 78.18M
Net Cash -317.88M
Net Cash / Share -7.14
Gross Margin 32.55%
Operating Margin -14.93%
Profit Margin -19.00%
FCF Margin 14.74%
ROA 5.51%
ROE -75.66%
ROIC -10.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (16)

Buy 5
Overweight 1
Hold 9
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

$18.78*
(-22.04% downside)
Low
15.0
Current: $24.09
High
22.0
Target: 18.78
*Average 12-month price target from 14 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue6687016485907981,0851,074981908795
Revenue Growth-4.66%8.19%9.76%-25.99%-26.51%1.09%9.42%8.09%14.22%-
Gross Profit173204183153265420411359314281
Operating Income96.6811911087.45161347333297251227
Net Income10279.5383.1363.90115257243216185145
Shares Outstanding44.3644.2144.1543.4842.7544.3645.6947.2146.2944.83
Earnings Per Share2.281.791.881.462.685.775.284.543.823.00
EPS Growth27.37%-4.79%28.77%-45.52%-53.55%9.28%16.3%18.85%27.33%-
Dividend Per Share2.202.202.202.202.202.001.281.121.000.89
Dividend Growth0%0%0%0%10%56.25%14.29%12%12.36%-
Operating Cash Flow89.53112124132219303298237204206
Capital Expenditures-21.56-22.05-18.45-10.96-22.94-36.56-37.91-32.13-29.25-27.13
Free Cash Flow67.9789.78106121196267260205175179
Cash & Equivalents11.0913.1214.4014.7622.4923.3525.0919.2329.33134
Total Debt382290227216431354267234223148
Net Cash / Debt-371-277-213-202-408-330-242-215-194-13.66
Assets775649585573625673661637611650
Liabilities593488436418649579492449429358
Book Value178157145151-29.0687.57163182178289
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Core Laboratories N.V.
Country Netherlands
Employees 3,800
CEO Lawrence V. Bruno

Stock Information

Ticker Symbol CLB
Stock Exchange New York Stock Exchange
Sector Energy
Industry Oil & Gas Equipment & Services
Unique Identifier NYSE: CLB
IPO Date September 20, 1995

Description

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment comprises services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.